Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving combination chemotherapy works in treating
young patients with recurrent or resistant malignant germ cell tumors. Drugs used in
chemotherapy, such as paclitaxel, ifosfamide, and carboplatin, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Giving more than one drug (combination chemotherapy) may kill more tumor cells.